Replicate
's headquarters is in San Diego, California. Nathaniel Wang is the Co-Founder & CEO of Replicate. Replicate's latest funding round was a Venture Round for $20M on Feb 2022. Replicate has 2 followers on Owler.Replicate
's headquarters is in San Diego, California. Nathaniel Wang is the Co-Founder & CEO of Replicate. Replicate's latest funding round was a Venture Round for $20M on Feb 2022. Replicate has 2 followers on Owler.
News
Sep 24, 2025
PR Newswire
Press Release: Replicate : Replicate Bioscience Announces Publication of Promising New Phase 1 Durability Data for Its srRNA Vaccine Candidate RBI-4000
Aug 31, 2025
Indian Pharma Post
Replicate: Novo Nordisk taps Replicate Bioscience's srRNA platform for obesity
Feb 07, 2025
StreetInsider
Press Release: Replicate : Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
Aug 21, 2024
StreetInsider
Press Release: Replicate : Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
May 11, 2024
PR Newswire
Press Release: Replicate : Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Apr 22, 2024
StreetInsider
Press Release: Replicate : Replicate Bioscience Announces Oral Presentations at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Mar 01, 2024
PR Newswire
Press Release: Replicate : Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
Feb 14, 2024
STAT News
Replicate: Replicate's srRNA rabies vaccine effective in Phase 1
Feb 14, 2024
PR Newswire
Press Release: Replicate : Replicate Bioscience Announces Positive Initial Clinical Results for its Next Generation srRNA Technology
Feb 14, 2024
Endpoints News
Replicate: Replicate Bioscience takes aim at mono-causing virus after promising results with mRNA rabies shot